Elephas Biosciences
AI software platform for clinical trial optimization and patient responder prediction
- Sector
- Medtech
- Headquarters
- MADISON, WI
- Founded
- 2020
- Latest Form D
- $51.2M, Jan 2024
- Total capital
- $114M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $114M
- 4 Form D · last Jan 2024
- 34 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 3
- 21 pending · first 2022
- Rank in peer group#20 of 73
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 4th filing$51.2M
- Private capital raisedForm D · SEC · 3rd filing$41.5M
- Private capital raisedForm D · SEC · 2nd filing$1M
- Private capital raisedForm D · SEC · 1st filing$20M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 73 peers
Line = medianMedtech · Platform
- Granted patents#20 · top 27%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Andrea K. JacksonDirectorNamed in SEC Form D filings
- Jonathan P. OlinerExecutive OfficerNamed in SEC Form D filings
- Maneesh K. AroraExecutive Officer, DirectorNamed in SEC Form D filings
- Michelle B. AroraDirectorNamed in SEC Form D filings
- Paul K. BernsDirectorNamed in SEC Form D filings
- Steven K. GalsonDirectorNamed in SEC Form D filings
Show all 7 people
- Terrence P. BradyExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 3 granted of 24- PendingTissue Cutting System And MethodUSPTOApplication 19418573
- GrantedSystems And Methods For Measuring Changes In Cellular Activity In Live TissueUSPTOUS 12,467,918
- PendingEx Vivo Systems And Methods For Determining The Effect Of A Drug Or Other Agent On A TissueUSPTOApplication 19196107
Show all 24 patent records
- Tissue Cutting System And MethodJun 4, 2026 · Application 19418573Pending
- Systems And Methods For Measuring Changes In Cellular Activity In Live TissueNov 11, 2025 · US 12,467,918Granted
- Ex Vivo Systems And Methods For Determining The Effect Of A Drug Or Other Agent On A TissueAug 21, 2025 · Application 19196107Pending
- Ex Vivo Systems And Methods For Determining The Effect Of A Drug Or Other Agent On A TissueMay 27, 2025 · US 12,313,624Granted
- Systems And Methods For Tissue Cutting System With VisionSep 12, 2024 · Application 18599465Pending
- Antibody Fragments And Uses Thereof For Imaging Cellular ActivitySep 21, 2023 · Application 18118977Pending
- Flow Cell And Sample Sorting SystemSep 21, 2023 · Application 18123069Pending
- Tissue Cutting System And MethodMar 16, 2023 · Application 17941289Pending
- Ex Vivo Systems And Methods For Determining The Effect Of A Drug Or Other Agent On A TissueJun 21, 2022 · US 11,366,101Granted
- Ex Vivo Systems And Methods To Assess Cellular Information In Live TissueApplication 63546014Pending
- Label-free Methods For Assessing Cell State In A Biological SampleApplication 63459804Pending
- Systems And Methods For Tissue Cutting System With VisionApplication PCTUS2024019005Pending
- Flow Cell And Sample Sorting SystemApplication PCTUS2023015520Pending
- Antibody Fragments And Uses Thereof For Imaging Cellular ActivityApplication PCTUS2023014808Pending
- Systems And Methods For Tissue Cutting System With VisionApplication 63450892Pending
- Label-free Methods For Assessing Cell State In A Biological SampleApplication PCTUS2024025016Pending
- Ex Vivo Systems And Methods To Assess Cellular Information In Live TissueApplication PCTUS2024053009Pending
- Tissue Cutting System And MethodApplication PCTUS2022043000Pending
- Systems And Methods For Measuring Changes In Cellular Activity In Live TissueApplication 63743964Pending
- Flow Cell And Sample Sorting SystemApplication 63321466Pending
- Antibody Fragments And Uses Thereof For Imaging Cellular ActivityApplication 63317681Pending
- Tissue Cutting System And MethodApplication 63313819Pending
- Ex Vivo Systems And Methods For Determining The Effect Of A Drug Or Other Agent On A TissueApplication PCTUS2021065696Pending
- Label-free Methods For Assessing Cell State In A Biological SampleApplication 19475618Pending
Related companies, and why
- OHIO WILLOW WOOD COMPANYSimilar federal contract value in Medtech · null in contracts
- BiorasisSimilar federal contract value in Medtech · null in contracts
- PEDIAMETRIX INC.Similar federal contract value in Medtech · null in contracts
- ApiJect Holdings, Inc.Similar federal contract value in Medtech · null in contracts
- KORTUC INC.Similar federal contract value in Medtech · null in contracts
- POPNEURON LLCSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .